...
首页> 外文期刊>Carbohydrate Polymers: Scientific and Technological Aspects of Industrially Important Polysaccharides >A mussel-inspired approach towards heparin-immobilized cellulose gel beads for selective removal of low density lipoprotein from whole blood
【24h】

A mussel-inspired approach towards heparin-immobilized cellulose gel beads for selective removal of low density lipoprotein from whole blood

机译:一种贻贝激发肝素固定化纤维素凝胶珠粒,用于从全血中选择性去除低密度脂蛋白

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this study, we report a mussel-inspired approach to fabricate heparin-immobilized cellulose (HeTaCe) gel beads with self-anticoagulative and biocompatible properties which can selectively remove low density lipoprotein (LDL) from whole blood directly. First, a phase inversion technique was applied to prepare cellulose gel beads. Then the as-prepared gel beads were dipped into a mixed solution of heparin and tannic acid in phosphate buffered saline (PBS, pH 8.5) to obtain HeTaCe gel beads. Blood compatibility experiments indicated that the HeTaCe gel beads could suppress complement activation as well as contact activation and prolong the clotting times to the upper detect limits (activated partial thromboplastin time >600?s and thrombin time >180?s) of the automated blood coagulation analyzer. An ideal adsorption capacity of LDLin vitrowas achieved by the HeTaCe gel beads with an amount of 79.1?mg/g. Besides, dynamic column adsorption test further demonstrated a selective adsorption of LDL without a significant reduction of high density lipoprotein (HDL) in a simulative hemoperfusion system. It is believed that the HeTaCe gel beads will be quite appealing to future clinical practice aiming at lowering LDL and improving the outcomes of patients with high cardiovascular risk.
机译:在这项研究中,我们报告了一种贻贝激发方法,用于制造具有自我抗凝和生物相容性的肝素 - 固定的纤维素(Hetace)凝胶珠粒,其可以直接选择性地从全血中选择性地除去低密度脂蛋白(LDL)。首先,施加相倒置技术以制备纤维素凝胶珠。然后将AS制备的凝胶珠浸入磷酸盐缓冲盐水(PBS,pH 8.5)中的肝素和单宁酸的混合溶液中以获得Hetace凝胶珠。血液相容性实验表明,Hetace凝胶珠粒可以抑制补体激活以及接触激活并延长凝血时间到上检测限制(活性部分血栓形成时间> 600〜S和凝血酶时间> 180〜180〜)的自动血液凝固分析仪。由Hetace凝胶珠子实现的Ldlin Vitrowas的理想吸附能力,其量为79.1μmg/ g。此外,动态柱吸附试验进一步证明了LDL的选择性吸附,在模拟血液灌注系统中没有显着降低高密度脂蛋白(HDL)。据信,Hetace凝胶珠子对未来的临床实践非常有吸引力,旨在降低LDL并改善高血管内风险患者的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号